Conversation with The Cancer LetterFree Matt Myers: Philip Morris has a long history of funding what it calls independent research by previously credible researchers October 06, 2017Vol.43 No.37By Paul Goldberg
Free How PR firms created “dialogue” structure used by cancer groups and tobacco clients October 06, 2017Vol.43 No.37By Paul Goldberg
Free Former American Cancer Society CEO John Seffrin endorses cancer research venture funded by Philip Morris October 06, 2017Vol.43 No.37By Paul Goldberg
FreeGuest Editorial How the RACE for Children Act will get drugs to kids with cancer September 08, 2017Vol.43 No.33By Nancy Goodman
Free NCI’s Lowy and Schiller win Lasker prize for developing HPV vaccine September 06, 2017Vol.43 No.33By Paul Goldberg
Conversation with The Cancer LetterFree Lowy: NCI’s intramural program made development of the HPV vaccine possible September 06, 2017Vol.43 No.33By Paul Goldberg
Conversation with The Cancer LetterFree Rita Redberg: FDA proposal to delay reporting of device malfunctions “should be tossed” July 28, 2017Vol.43 No.30By Matthew Bin Han Ong
Drugs & TargetsFree FDA approves treatment to reduce risk of breast cancer returning July 21, 2017Vol.43 No.29
Drugs & TargetsFree FDA accepts for priority review BMS application for dasatinib in children with CP Ph+ CML July 21, 2017Vol.43 No.29
